Morgan Stanley Upgrades ShockWave Medical to Overweight, Raises Price Target to $335
Portfolio Pulse from richadhand@benzinga.com
Morgan Stanley analyst Patrick Wood has upgraded ShockWave Medical (NASDAQ:SWAV) from Equal-Weight to Overweight and raised the price target from $291 to $335.
July 10, 2023 | 1:43 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
ShockWave Medical has been upgraded to Overweight by Morgan Stanley, with a raised price target of $335.
The upgrade from Morgan Stanley is a positive signal for ShockWave Medical. The raised price target indicates that the analyst sees potential for the stock's price to increase, which could attract investors and drive up the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100